carbamazepine
Generic: carbamazepine
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
carbamazepine
Generic Name
carbamazepine
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
TABLET
Routes
Active Ingredients
carbamazepine 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
43353-953
Product ID
43353-953_7c7b8491-2291-48de-8b76-bf2eca6c9d9c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075948
Listing Expiration
2026-12-31
Marketing Start
2014-03-07
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43353953
Hyphenated Format
43353-953
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbamazepine (source: ndc)
Generic Name
carbamazepine (source: ndc)
Application Number
ANDA075948 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 60 TABLET in 1 BOTTLE (43353-953-53)
- 90 TABLET in 1 BOTTLE (43353-953-60)
- 180 TABLET in 1 BOTTLE (43353-953-80)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7c7b8491-2291-48de-8b76-bf2eca6c9d9c", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308979"], "spl_set_id": ["c1fc31ef-6b2e-4de4-a185-ec44e94e7b40"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (43353-953-53)", "package_ndc": "43353-953-53", "marketing_start_date": "20140703"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (43353-953-60)", "package_ndc": "43353-953-60", "marketing_start_date": "20140703"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (43353-953-80)", "package_ndc": "43353-953-80", "marketing_start_date": "20140725"}], "brand_name": "CARBAMAZEPINE", "product_id": "43353-953_7c7b8491-2291-48de-8b76-bf2eca6c9d9c", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "43353-953", "generic_name": "CARBAMAZEPINE", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARBAMAZEPINE", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA075948", "marketing_category": "ANDA", "marketing_start_date": "20140307", "listing_expiration_date": "20261231"}